6th Latin American Regulatory Conference (LARC) 2014

Latin American markets have become more vulnerable to and negatively impacted by the international movement of spurious, substandard, falsified, falsely-labeled and counterfeit (SSFFC) medical products. This session will focus on the region’s efforts and initiatives to ensure that the trade in legitimate products is not disrupted. Specific areas to be discussed, include, but are not limited to, a) good distribution practices, b) controls on components used as part of good manufacturing practices and quality management systems, c) import and export practices, d) dispensing practices via the Internet, e) detection technologies, among others.